Key result
Actual ED admission rates for unexplained syncope do not significantly exceed ESC or CSRS guidelines.
Why the study?
Syncope of unknown origin is challenging, with variable investigation and admission rates despite standardization attempts, while implantable cardiac monitors streamline work-up.
Do ED admission rates and management for syncope of unknown origin align with ESC and CSRS guidelines?
Observational (n=50)
No
Do ED admission rates and management for syncope of unknown origin align with ESC and CSRS guidelines?
Absolute Event Rate: 64% vs 60%
Real-world ED management of syncope of unknown origin demonstrates admission rates comparable to ESC and CSRS guidelines, with appropriate utilization of implantable cardiac monitors.
No takes yet. Share an insight, caveat, or question.
Admission rates align with ESC/CSRS guidelines; supports consensus but leaves open need for prospective validation.
Blasutti et al. (2026) conducted an observational in Syncope of unknown origin (n=50). Hospital admission and implantable cardiac monitor (ICM) insertion vs. ESC 2018 guidelines and Canadian Syncope Risk Score (CSRS) recommendations was evaluated on Admission rates compared to ESC and CSRS recommendations. Actual admission rates for syncope of unknown origin (64%) were not significantly higher than those recommended by ESC (60%) or CSRS (54%) guidelines.